imidazo[1,2-c]pyrimidine derivatives (Kissei)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameimidazo[1,2-c]pyrimidine derivatives (Kissei)
Drug Alias NameSyk family kinases inhibitors (Kissei)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ZAP-70 inhibitorsSpleen tyrosine kinase inhibitors
TargetsTyrosine-protein kinase ZAP-70Spleen tyrosine kinase
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKissei Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A